Treatment of Pseudomyxoma Peritonei with Two Times- Cytoreduction and Hypertermic Antiblastic Peritoneal Perfusion (HAPP)

Michele De Simone, S. Scuderi, M. Vaira, D. Costamagna, R. Barone, G. Fiorentini, P. Dentico, A. Caponi, B. Ciaccio, C. Caponi, L. Ferri, E. Martini, S. Cantini

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Pseudomyxoma peritonei is a rare neoplasia with a low grade of clinical malignity in which neoplastic masses product large amount of mucinous material. Its treatment advocates an aggressive cytoreduction of all visceral and peritoneal lesions and Hyperthermic Antiblastic Peritoneal Perfusion (HAPP). In three cases we programmed a two stage surgical approach for the massive amount of peritoneal implants. Two times we achieved our aim, while one time, the wide progression of the disease during the two surgical procedures made useless our efforts to have a complete cytoreduction and the following HAPP. This last patient refused systemic chemotherapy between the two surgeries and we think that this should be one of the reasons of the failure.

Original languageEnglish
Pages (from-to)25-28
Number of pages4
JournalJournal of Experimental and Clinical Cancer Research
Volume22
Issue number4 SUPPL.
Publication statusPublished - Dec 2003

Fingerprint

Pseudomyxoma Peritonei
Perfusion
Disease Progression
Drug Therapy
Therapeutics
Neoplasms

Keywords

  • Cytoreduction
  • Intraperitoneal chemotherapy
  • Pseudomyxoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Treatment of Pseudomyxoma Peritonei with Two Times- Cytoreduction and Hypertermic Antiblastic Peritoneal Perfusion (HAPP). / De Simone, Michele; Scuderi, S.; Vaira, M.; Costamagna, D.; Barone, R.; Fiorentini, G.; Dentico, P.; Caponi, A.; Ciaccio, B.; Caponi, C.; Ferri, L.; Martini, E.; Cantini, S.

In: Journal of Experimental and Clinical Cancer Research, Vol. 22, No. 4 SUPPL., 12.2003, p. 25-28.

Research output: Contribution to journalArticle

De Simone, M, Scuderi, S, Vaira, M, Costamagna, D, Barone, R, Fiorentini, G, Dentico, P, Caponi, A, Ciaccio, B, Caponi, C, Ferri, L, Martini, E & Cantini, S 2003, 'Treatment of Pseudomyxoma Peritonei with Two Times- Cytoreduction and Hypertermic Antiblastic Peritoneal Perfusion (HAPP)', Journal of Experimental and Clinical Cancer Research, vol. 22, no. 4 SUPPL., pp. 25-28.
De Simone, Michele ; Scuderi, S. ; Vaira, M. ; Costamagna, D. ; Barone, R. ; Fiorentini, G. ; Dentico, P. ; Caponi, A. ; Ciaccio, B. ; Caponi, C. ; Ferri, L. ; Martini, E. ; Cantini, S. / Treatment of Pseudomyxoma Peritonei with Two Times- Cytoreduction and Hypertermic Antiblastic Peritoneal Perfusion (HAPP). In: Journal of Experimental and Clinical Cancer Research. 2003 ; Vol. 22, No. 4 SUPPL. pp. 25-28.
@article{786c11ae4cc041a780ecb9470d77809b,
title = "Treatment of Pseudomyxoma Peritonei with Two Times- Cytoreduction and Hypertermic Antiblastic Peritoneal Perfusion (HAPP)",
abstract = "Pseudomyxoma peritonei is a rare neoplasia with a low grade of clinical malignity in which neoplastic masses product large amount of mucinous material. Its treatment advocates an aggressive cytoreduction of all visceral and peritoneal lesions and Hyperthermic Antiblastic Peritoneal Perfusion (HAPP). In three cases we programmed a two stage surgical approach for the massive amount of peritoneal implants. Two times we achieved our aim, while one time, the wide progression of the disease during the two surgical procedures made useless our efforts to have a complete cytoreduction and the following HAPP. This last patient refused systemic chemotherapy between the two surgeries and we think that this should be one of the reasons of the failure.",
keywords = "Cytoreduction, Intraperitoneal chemotherapy, Pseudomyxoma",
author = "{De Simone}, Michele and S. Scuderi and M. Vaira and D. Costamagna and R. Barone and G. Fiorentini and P. Dentico and A. Caponi and B. Ciaccio and C. Caponi and L. Ferri and E. Martini and S. Cantini",
year = "2003",
month = "12",
language = "English",
volume = "22",
pages = "25--28",
journal = "Journal of Experimental and Clinical Cancer Research",
issn = "0392-9078",
publisher = "BioMed Central Ltd.",
number = "4 SUPPL.",

}

TY - JOUR

T1 - Treatment of Pseudomyxoma Peritonei with Two Times- Cytoreduction and Hypertermic Antiblastic Peritoneal Perfusion (HAPP)

AU - De Simone, Michele

AU - Scuderi, S.

AU - Vaira, M.

AU - Costamagna, D.

AU - Barone, R.

AU - Fiorentini, G.

AU - Dentico, P.

AU - Caponi, A.

AU - Ciaccio, B.

AU - Caponi, C.

AU - Ferri, L.

AU - Martini, E.

AU - Cantini, S.

PY - 2003/12

Y1 - 2003/12

N2 - Pseudomyxoma peritonei is a rare neoplasia with a low grade of clinical malignity in which neoplastic masses product large amount of mucinous material. Its treatment advocates an aggressive cytoreduction of all visceral and peritoneal lesions and Hyperthermic Antiblastic Peritoneal Perfusion (HAPP). In three cases we programmed a two stage surgical approach for the massive amount of peritoneal implants. Two times we achieved our aim, while one time, the wide progression of the disease during the two surgical procedures made useless our efforts to have a complete cytoreduction and the following HAPP. This last patient refused systemic chemotherapy between the two surgeries and we think that this should be one of the reasons of the failure.

AB - Pseudomyxoma peritonei is a rare neoplasia with a low grade of clinical malignity in which neoplastic masses product large amount of mucinous material. Its treatment advocates an aggressive cytoreduction of all visceral and peritoneal lesions and Hyperthermic Antiblastic Peritoneal Perfusion (HAPP). In three cases we programmed a two stage surgical approach for the massive amount of peritoneal implants. Two times we achieved our aim, while one time, the wide progression of the disease during the two surgical procedures made useless our efforts to have a complete cytoreduction and the following HAPP. This last patient refused systemic chemotherapy between the two surgeries and we think that this should be one of the reasons of the failure.

KW - Cytoreduction

KW - Intraperitoneal chemotherapy

KW - Pseudomyxoma

UR - http://www.scopus.com/inward/record.url?scp=12144286546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12144286546&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 25

EP - 28

JO - Journal of Experimental and Clinical Cancer Research

JF - Journal of Experimental and Clinical Cancer Research

SN - 0392-9078

IS - 4 SUPPL.

ER -